Bajaj Healthcare Limited (BAJAJHCARE) — Board Meeting

· NSE 🟡 Notable Neutral
📢 Key Event
Board approved utilization of Rs. 52.71 crore unutilized proceeds for capital expenditure and revised GCP definition on March 18, 2026.
🔄 What Changed
Rs. 52.71 crore unutilized proceeds approved for capital expenditure and GCP definition expanded to include loan repayment.
🔮 What's Next
Board approved utilization of Rs. 52.71 crore for capital expenditure and GCP purposes in March 2026 meeting.
💡 Investor Takeaway
Shareholders should note the board's approval to deploy unutilized funds for capital expenditure and expanded GCP definition covering loan repayments.

Bajaj Healthcare Limited received a Monitoring Agency Report from CARE Ratings confirming proper utilization of Rs. 204.97 crore raised via preferential issue, with full conversion of warrants and revised General Corporate Purpose definition approved by board on March 18, 2026.

📄 View Original Announcement (PDF)

About Bajaj Healthcare Limited (BAJAJHCARE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹956.52 Cr P/E: 44.9

View full BAJAJHCARE stock details →

📡 Get AI alerts when BAJAJHCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BAJAJHCARE — Free

📊 More BAJAJHCARE filings

See all BAJAJHCARE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when BAJAJHCARE files new disclosures

Track BAJAJHCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BAJAJHCARE — Free

Free account · 2 AI queries/day